YIC-C8-434

Overview

YIC-C8-434 is an orally active ACAT inhibitor. YIC-C8-434 selectively blocks cholesterol esterification in intestinal epithelial cells and hepatocytes without affecting the production of triglycerides or phospholipids . YIC-C8-434 effectively reduces intracellular cholesteryl ester levels and induces an increase in lipid droplet volume, exhibiting excellent cholesterol-lowering activity and safety. YIC-C8-434 disrupts the assembly of hepatitis C virus ( HCV ) virions, reduces HCV RNA synthesis and viral particle release. YIC-C8-434 can be used in studies related to hepatitis C virus infection .

Application

Products | Products > Disease Areas > Infection | Products > Disease Areas > Hepatitis Virus Infection | Products > Disease Areas > HCV Protease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Infection | Products > Signaling Pathways > Acyltransferase

Product Information

• Catalog No.: HY-138198A
• CAS No.: 214265-97-1
• Molecular Formula: C31H44N2O4
• Molecular Weight: 508.69
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source